Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001214659-22-003623)

Filing Details

Accession Number:: 0001214659-22-003623
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-04 06:06:43
Reporting Period:: 2022-03-02

Accepted Time:: 2022-03-04 06:06:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1293310	Humanigen Inc	HGEN	Pharmaceutical Preparations (2834)	770557236

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1421882	Cameron Durrant	C/O Humanigen, Inc. 830 Morris Turnpike 4Th Floor Short Hills NJ 07078	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-02	40,000	$2.34	70,000	No	4	P	Indirect	By Cameron Durrant Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Cameron Durrant Revocable Trust

Footnotes

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.295 to $2.34, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.